Based on the Likert scale, most patients with atopic dermatitis (AD) using baricitinib reported being either “satisfied” (76%) or “very satisfied” (18%). Most patients with atopic dermatitis (AD) ...
This posting is a sidebar, a bit of a rant. But if I can be a small part of saving the Likert Scale from death by its ongoing misuse, it'll have been worthwhile. You may receive a phone call about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback